Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 261

1.

Identification of a specific ultrasonographic finding for differentiating hepatic angiomyolipoma from hepatocellular carcinoma.

Naito K, Shigematsu Y, Fujiwara Y, Inamura K, Togashi Y, Inoue Y, Takazawa Y, Kanda H, Matsueda K.

Clin Imaging. 2019 Nov 27;59(2):104-108. doi: 10.1016/j.clinimag.2019.10.020. [Epub ahead of print]

PMID:
31812881
2.

Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer.

Fujiwara R, Inamura K, Yuasa T, Numao N, Yamamoto S, Masuda H, Kawauchi A, Takeuchi K, Yonese J.

Int J Clin Oncol. 2019 Sep 14. doi: 10.1007/s10147-019-01542-7. [Epub ahead of print]

PMID:
31522314
3.

Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma.

Inamura K, Amori G, Yuasa T, Yamamoto S, Yonese J, Ishikawa Y.

Cancer Manag Res. 2019 Jul 25;11:7021-7030. doi: 10.2147/CMAR.S209205. eCollection 2019.

4.

Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells.

Koh H, Hamada T, Song M, Liu L, Cao Y, Nowak JA, da Silva A, Twombly T, Morikawa T, Kim SA, Masugi Y, Kosumi K, Shi Y, Gu M, Li W, Du C, Chen Y, Li W, Liu H, Li C, Wu K, Nosho K, Inamura K, Hanyuda A, Zhang X, Giannakis M, Chan AT, Fuchs CS, Nishihara R, Meyerhardt JA, Ogino S.

JNCI Cancer Spectr. 2018 Oct;2(4):pky058. doi: 10.1093/jncics/pky058. Epub 2019 Jan 9.

5.

Preparation of metal phthalocyanine (MPc)-polymer complexes: the possible anti-cancer properties of FePc-polymer complexes.

Inamura I, Inamura K, Jinbo Y, Mihara T, Sasaoka Y.

Heliyon. 2019 Mar 29;5(3):e01383. doi: 10.1016/j.heliyon.2019.e01383. eCollection 2019 Mar.

6.

Cerebral Thromboembolism after Lobectomy for Lung Cancer: Pathological Diagnosis and Mechanism of Thrombus Formation.

Hashimoto H, Usui G, Tsugeno Y, Sugita K, Amori G, Morikawa T, Inamura K.

Cancers (Basel). 2019 Apr 5;11(4). pii: E488. doi: 10.3390/cancers11040488. Review.

7.

A case report on 111In chloride bone marrow scintigraphy in management of adrenal myelolipoma.

Yamamoto T, Koizumi M, Kohno A, Numao N, Inamura K.

Medicine (Baltimore). 2019 Feb;98(8):e14625. doi: 10.1097/MD.0000000000014625.

8.

Mesenchymal tumors of the lung: diagnostic pathology, molecular pathogenesis, and identified biomarkers.

Hashimoto H, Tsugeno Y, Sugita K, Inamura K.

J Thorac Dis. 2019 Jan;11(Suppl 1):S9-S24. doi: 10.21037/jtd.2018.12.04. Review.

9.

Identification of Multisialylated LacdiNAc Structures as Highly Prostate Cancer Specific Glycan Signatures on PSA.

Haga Y, Uemura M, Baba S, Inamura K, Takeuchi K, Nonomura N, Ueda K.

Anal Chem. 2019 Feb 5;91(3):2247-2254. doi: 10.1021/acs.analchem.8b04829. Epub 2019 Jan 23.

PMID:
30669833
10.

Gut microbiome: a key player in cancer immunotherapy.

Shigematsu Y, Inamura K.

Hepatobiliary Surg Nutr. 2018 Dec;7(6):479-480. doi: 10.21037/hbsn.2018.10.02. No abstract available.

11.

Sex differences in the severity of neuropsychiatric symptoms and their relationship with clinico-demographic and psychosocial factors in patients with amnestic mild cognitive impairment and mild Alzheimer's disease.

Inamura K, Shinagawa S, Tsuneizumi Y, Nagata T, Tagai K, Nukariya K, Shigeta M.

Aging Ment Health. 2018 Dec 27:1-8. doi: 10.1080/13607863.2018.1539834. [Epub ahead of print]

PMID:
30588827
12.

SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance.

Wasserman I, Lee LH, Ogino S, Marco MR, Wu C, Chen X, Datta J, Sadot E, Szeglin B, Guillem JG, Paty PB, Weiser MR, Nash GM, Saltz L, Barlas A, Manova-Todorova K, Uppada SPB, Elghouayel AE, Ntiamoah P, Glickman JN, Hamada T, Kosumi K, Inamura K, Chan AT, Nishihara R, Cercek A, Ganesh K, Kemeny NE, Dhawan P, Yaeger R, Sawyers CL, Garcia-Aguilar J, Giannakis M, Shia J, Smith JJ.

Clin Cancer Res. 2019 Mar 15;25(6):1948-1956. doi: 10.1158/1078-0432.CCR-18-1726. Epub 2018 Dec 26.

PMID:
30587545
13.

Inhibitory effect of hybrid liposomes on the growth of liver cancer stem cells.

Inamura K, Komizu Y, Yamakuchi M, Ishida S, Matsumoto Y, Matsushita T.

Biochem Biophys Res Commun. 2019 Jan 29;509(1):268-274. doi: 10.1016/j.bbrc.2018.12.118. Epub 2018 Dec 21.

14.

Unique MicroRNA and mRNA Interactions in EGFR-Mutated Lung Adenocarcinoma.

Subat S, Inamura K, Ninomiya H, Nagano H, Okumura S, Ishikawa Y.

J Clin Med. 2018 Nov 6;7(11). pii: E419. doi: 10.3390/jcm7110419.

15.

Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.

Shigematsu Y, Inamura K, Yamamoto N, Mise Y, Saiura A, Ishikawa Y, Takahashi S, Kanda H.

BMC Cancer. 2018 Oct 16;18(1):980. doi: 10.1186/s12885-018-4902-8.

16.

Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status.

Hamada T, Zhang X, Mima K, Bullman S, Sukawa Y, Nowak JA, Kosumi K, Masugi Y, Twombly TS, Cao Y, Song M, Liu L, da Silva A, Shi Y, Gu M, Li W, Koh H, Nosho K, Inamura K, Keum N, Wu K, Meyerhardt JA, Kostic AD, Huttenhower C, Garrett WS, Meyerson M, Giovannucci EL, Chan AT, Fuchs CS, Nishihara R, Giannakis M, Ogino S.

Cancer Immunol Res. 2018 Nov;6(11):1327-1336. doi: 10.1158/2326-6066.CIR-18-0174. Epub 2018 Sep 18.

17.

Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.

Hamada T, Liu L, Nowak JA, Mima K, Cao Y, Ng K, Twombly TS, Song M, Jung S, Dou R, Masugi Y, Kosumi K, Shi Y, da Silva A, Gu M, Li W, Keum N, Wu K, Nosho K, Inamura K, Meyerhardt JA, Nevo D, Wang M, Giannakis M, Chan AT, Giovannucci EL, Fuchs CS, Nishihara R, Zhang X, Ogino S.

Eur J Cancer. 2018 Nov;103:98-107. doi: 10.1016/j.ejca.2018.07.130. Epub 2018 Sep 13.

18.

CSF1R-Expressing Tumor-Associated Macrophages, Smoking and Survival in Lung Adenocarcinoma: Analyses Using Quantitative Phosphor-Integrated Dot Staining.

Inamura K, Shigematsu Y, Ninomiya H, Nakashima Y, Kobayashi M, Saito H, Takahashi K, Futaya E, Okumura S, Ishikawa Y, Kanda H.

Cancers (Basel). 2018 Jul 31;10(8). pii: E252. doi: 10.3390/cancers10080252.

19.

Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer.

Inamura K, Takazawa Y, Inoue Y, Yokouchi Y, Kobayashi M, Saiura A, Shibutani T, Ishikawa Y.

J Clin Med. 2018 Jul 10;7(7). pii: E172. doi: 10.3390/jcm7070172.

20.

TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas.

Hamada T, Soong TR, Masugi Y, Kosumi K, Nowak JA, da Silva A, Mu XJ, Twombly TS, Koh H, Yang J, Song M, Liu L, Gu M, Shi Y, Nosho K, Morikawa T, Inamura K, Shukla SA, Wu CJ, Garraway LA, Zhang X, Wu K, Meyerhardt JA, Chan AT, Glickman JN, Rodig SJ, Freeman GJ, Fuchs CS, Nishihara R, Giannakis M, Ogino S.

Oncoimmunology. 2018 Mar 19;7(7):e1442999. doi: 10.1080/2162402X.2018.1442999. eCollection 2018.

21.
22.

CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan.

Shigematsu Y, Inamura K, Mise Y, Saiura A, Rehnberg E, Yamamoto N, Ishikawa Y, Takahashi S, Kanda H.

Oncotarget. 2018 Mar 30;9(24):17056-17065. doi: 10.18632/oncotarget.24842. eCollection 2018 Mar 30.

23.

Bladder Cancer: New Insights into Its Molecular Pathology.

Inamura K.

Cancers (Basel). 2018 Apr 1;10(4). pii: E100. doi: 10.3390/cancers10040100. Review.

24.

Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification.

Inamura K.

Oncotarget. 2018 Feb 16;9(18):14723-14737. doi: 10.18632/oncotarget.24515. eCollection 2018 Mar 6. Review.

25.

Update on Immunohistochemistry for the Diagnosis of Lung Cancer.

Inamura K.

Cancers (Basel). 2018 Mar 14;10(3). pii: E72. doi: 10.3390/cancers10030072. Review.

26.

Genetic Mechanisms of Immune Evasion in Colorectal Cancer.

Grasso CS, Giannakis M, Wells DK, Hamada T, Mu XJ, Quist M, Nowak JA, Nishihara R, Qian ZR, Inamura K, Morikawa T, Nosho K, Abril-Rodriguez G, Connolly C, Escuin-Ordinas H, Geybels MS, Grady WM, Hsu L, Hu-Lieskovan S, Huyghe JR, Kim YJ, Krystofinski P, Leiserson MDM, Montoya DJ, Nadel BB, Pellegrini M, Pritchard CC, Puig-Saus C, Quist EH, Raphael BJ, Salipante SJ, Shin DS, Shinbrot E, Shirts B, Shukla S, Stanford JL, Sun W, Tsoi J, Upfill-Brown A, Wheeler DA, Wu CJ, Yu M, Zaidi SH, Zaretsky JM, Gabriel SB, Lander ES, Garraway LA, Hudson TJ, Fuchs CS, Ribas A, Ogino S, Peters U.

Cancer Discov. 2018 Jun;8(6):730-749. doi: 10.1158/2159-8290.CD-17-1327. Epub 2018 Mar 6.

27.

Anosognosia in mild Alzheimer's disease is correlated with not only neural dysfunction but also compensation.

Tagai K, Shinagawa S, Kada H, Inamura K, Nagata T, Nakayama K.

Psychogeriatrics. 2018 Mar;18(2):81-88. doi: 10.1111/psyg.12287. Epub 2018 Feb 6.

PMID:
29409154
28.

Colorectal Cancers: An Update on Their Molecular Pathology.

Inamura K.

Cancers (Basel). 2018 Jan 20;10(1). pii: E26. doi: 10.3390/cancers10010026. Review.

29.

Diagnostic Ability with Abbreviated Biparametric and Full Multiparametric Prostate MR Imaging: Is the Use of PI-RADS Version 2 Appropriate for Comparison?

Kaji Y, Inamura K.

Radiology. 2018 Feb;286(2):726-727. doi: 10.1148/radiol.2017172265. No abstract available.

PMID:
29356639
30.

Osteosarcoma arising in fibrous dysplasia, confirmed by mutational analysis of GNAS gene.

Sugiura Y, Kanda H, Motoi N, Nomura K, Inamura K, Okada E, Matsumoto H, Shimoji T, Matsumoto S, Nakayama J, Takazawa Y, Ishikawa Y, Machinami R.

Pathol Res Pract. 2018 Feb;214(2):318-324. doi: 10.1016/j.prp.2017.10.018. Epub 2017 Nov 12.

PMID:
29268950
31.

Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.

Miyazawa M, Takatori H, Shimakami T, Kawaguchi K, Kitamura K, Arai K, Matsuda K, Sanada T, Urabe T, Inamura K, Kagaya T, Mizuno H, Fuchizaki U, Yamashita T, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Kaneko S.

PLoS One. 2017 Nov 22;12(11):e0188549. doi: 10.1371/journal.pone.0188549. eCollection 2017.

32.

[A case of gastric follicular lymphoma resected and diagnosed with laparoscopy and endoscopy cooperative surgery].

Seike T, Inamura K, Okuno N, Asaumi Y, Takata Y, Okamura T, Matano S, Terahata S, Sakatoku K, Kawai H.

Nihon Shokakibyo Gakkai Zasshi. 2017;114(11):1996-2004. doi: 10.11405/nisshoshi.114.1996. Review. Japanese.

PMID:
29109348
33.

Prognostic Effect of Lymphovascular Invasion on TNM Staging in Stage I Non-Small-cell Lung Cancer.

Noma D, Inamura K, Matsuura Y, Hirata Y, Nakajima T, Yamazaki H, Hirai Y, Ichinose J, Nakao M, Ninomiya H, Mun M, Nakagawa K, Masuda M, Ishikawa Y, Okumura S.

Clin Lung Cancer. 2018 Jan;19(1):e109-e122. doi: 10.1016/j.cllc.2017.06.001. Epub 2017 Jun 20.

PMID:
29066222
34.

Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification.

Inamura K.

Int J Mol Sci. 2017 Oct 20;18(10). pii: E2195. doi: 10.3390/ijms18102195. Review.

35.

Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.

Masugi Y, Nishihara R, Hamada T, Song M, da Silva A, Kosumi K, Gu M, Shi Y, Li W, Liu L, Nevo D, Inamura K, Cao Y, Liao X, Nosho K, Chan AT, Giannakis M, Bass AJ, Hodi FS, Freeman GJ, Rodig SJ, Fuchs CS, Qian ZR, Nowak JA, Ogino S.

Cancer Immunol Res. 2017 Nov;5(11):1046-1055. doi: 10.1158/2326-6066.CIR-17-0122. Epub 2017 Oct 16.

36.

Pilot study on novel blood containers with alternative plasticizers for red cell concentrate storage.

Morishita Y, Nomura Y, Fukui C, Kawakami T, Ikeda T, Mukai T, Yuba T, Inamura KI, Yamaoka H, Miyazaki KI, Okazaki H, Haishima Y.

PLoS One. 2017 Sep 28;12(9):e0185737. doi: 10.1371/journal.pone.0185737. eCollection 2017.

37.

Relationship of tumor PD-L1 (CD274) expression with lower mortality in lung high-grade neuroendocrine tumor.

Inamura K, Yokouchi Y, Kobayashi M, Ninomiya H, Sakakibara R, Nishio M, Okumura S, Ishikawa Y.

Cancer Med. 2017 Oct;6(10):2347-2356. doi: 10.1002/cam4.1172. Epub 2017 Sep 18.

38.

Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.

Inamura K.

Front Oncol. 2017 Aug 28;7:193. doi: 10.3389/fonc.2017.00193. eCollection 2017. Review.

39.

Skene's gland adenocarcinoma with intestinal differentiation: A case report and literature review.

Muto M, Inamura K, Ozawa N, Endo T, Masuda H, Yonese J, Ishikawa Y.

Pathol Int. 2017 Nov;67(11):575-579. doi: 10.1111/pin.12571. Epub 2017 Sep 5. Review.

PMID:
28872768
40.

Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.

Liu L, Nishihara R, Qian ZR, Tabung FK, Nevo D, Zhang X, Song M, Cao Y, Mima K, Masugi Y, Shi Y, da Silva A, Twombly T, Gu M, Li W, Hamada T, Kosumi K, Inamura K, Nowak JA, Drew DA, Lochhead P, Nosho K, Wu K, Wang M, Garrett WS, Chan AT, Fuchs CS, Giovannucci EL, Ogino S.

Gastroenterology. 2017 Dec;153(6):1517-1530.e14. doi: 10.1053/j.gastro.2017.08.045. Epub 2017 Sep 1.

41.

Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features.

Inamura K.

Cancers (Basel). 2017 Aug 29;9(9). pii: E111. doi: 10.3390/cancers9090111. Review.

42.

[Diagnostic Impact of 3D-CT with Retrograde Pyelography for Ureteropelvic Junction Obstruction : A Case Report].

Takei K, Abe H, Nishihara D, Mizuno T, Tokura Y, Suzuki I, Sakamoto K, Yuki H, Kambara T, Betsunou H, Yashi M, Fukabori Y, Kamai T, Inamura K, Shioyama Y, Kaji Y.

Hinyokika Kiyo. 2017 Jul;63(7):267-270. doi: 10.14989/ActaUrolJap_63_7_267. Japanese.

43.

Evaluation of an e-learning system for diagnosis of gastric lesions using magnifying narrow-band imaging: a multicenter randomized controlled study.

Nakanishi H, Doyama H, Ishikawa H, Uedo N, Gotoda T, Kato M, Nagao S, Nagami Y, Aoyagi H, Imagawa A, Kodaira J, Mitsui S, Kobayashi N, Muto M, Takatori H, Abe T, Tsujii M, Watari J, Ishiyama S, Oda I, Ono H, Kaneko K, Yokoi C, Ueo T, Uchita K, Matsumoto K, Kanesaka T, Morita Y, Katsuki S, Nishikawa J, Inamura K, Kinjo T, Yamamoto K, Yoshimura D, Araki H, Kashida H, Hosokawa A, Mori H, Yamashita H, Motohashi O, Kobayashi K, Hirayama M, Kobayashi H, Endo M, Yamano H, Murakami K, Koike T, Hirasawa K, Miyaoka Y, Hamamoto H, Hikichi T, Hanabata N, Shimoda R, Hori S, Sato T, Kodashima S, Okada H, Mannami T, Yamamoto S, Niwa Y, Yashima K, Tanabe S, Satoh H, Sasaki F, Yamazato T, Ikeda Y, Nishisaki H, Nakagawa M, Matsuda A, Tamura F, Nishiyama H, Arita K, Kawasaki K, Hoppo K, Oka M, Ishihara S, Mukasa M, Minamino H, Yao K.

Endoscopy. 2017 Oct;49(10):957-967. doi: 10.1055/s-0043-111888. Epub 2017 Jun 21.

PMID:
28637065
44.

Neurochemical and neuropharmacological characterization of ASP2905, a novel potent selective inhibitor of the potassium channel KCNH3.

Takahashi S, Inamura K, Yarimizu J, Yamazaki M, Murai N, Ni K.

Eur J Pharmacol. 2017 Sep 5;810:26-35. doi: 10.1016/j.ejphar.2017.05.045. Epub 2017 May 25.

PMID:
28552344
45.

A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder.

Inamura K, Kobayashi M, Nagano H, Sugiura Y, Ogawa M, Masuda H, Yonese J, Ishikawa Y.

Hum Pathol. 2017 Nov;69:96-100. doi: 10.1016/j.humpath.2017.04.022. Epub 2017 May 10.

PMID:
28504207
46.

Alternative plasticizer, 4-cyclohexene-1,2-dicarboxylic acid dinonyl ester, for blood containers with protective effects on red blood cells and improved cold resistance.

Morishita Y, Nomura Y, Fukui C, Fujisawa A, Watanabe K, Fujimaki H, Kumada H, Inoue K, Morikawa T, Takahashi M, Kawakami T, Sakoda H, Mukai T, Yuba T, Inamura KI, Tanoue A, Miyazaki KI, Chung UI, Ogawa K, Yoshida M, Haishima Y.

J Biomed Mater Res B Appl Biomater. 2018 Apr;106(3):1052-1063. doi: 10.1002/jbm.b.33916. Epub 2017 May 13.

PMID:
28500731
47.

Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer.

Inamura K.

Cells. 2017 May 9;6(2). pii: E12. doi: 10.3390/cells6020012. Review.

48.

Diagnostic and Therapeutic Potential of MicroRNAs in Lung Cancer.

Inamura K.

Cancers (Basel). 2017 May 9;9(5). pii: E49. doi: 10.3390/cancers9050049. Review.

49.

Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.

Inamura K, Yokouchi Y, Kobayashi M, Ninomiya H, Sakakibara R, Subat S, Nagano H, Nomura K, Okumura S, Shibutani T, Ishikawa Y.

Oncotarget. 2017 Apr 25;8(17):28725-28735. doi: 10.18632/oncotarget.15647.

50.

Guest editorial for the IJCARS special issue on JAMIT 2015 and 2016.

Shimizu A, Sato Y, Inamura K.

Int J Comput Assist Radiol Surg. 2017 May;12(5):705-706. doi: 10.1007/s11548-017-1581-x. No abstract available.

PMID:
28391582

Supplemental Content

Loading ...
Support Center